EcoDrugPlus

Toll Like Receptor 2

Ensembl ID : ENSONIG00000030719
Gene Symbol: TLR2
3 Cross references
170 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSONIG00000039852
Gene Symbol: TLR2
1 Cross references
173 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSONIG00000020676
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSONIG00000031864
Gene Symbol: TLR8
1 Cross references
180 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSONIG00000027532
Gene Symbol: TLR8
1 Cross references
178 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSONIG00000029593
Gene Symbol: TLR8
1 Cross references
179 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSONIG00000020710
Gene Symbol: TAAR1
4 Cross references
376 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSONIG00000020712
Gene Symbol: TAAR1
1 Cross references
426 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSONIG00000035553
Gene Symbol: TAAR1
1 Cross references
428 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSONIG00000035579
Gene Symbol: TAAR1
1 Cross references
426 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSONIG00000014279
Gene Symbol: TRPA1
4 Cross references
200 Possible Orthologues:

Transmembrane Emp24 Domain-Containing Protein 3

Ensembl ID : ENSONIG00000002577
Gene Symbol: LOC100702682
4 Cross references
186 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).